Literature DB >> 29601387

CORR Insights®: What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Ying-Lee Lam1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29601387      PMCID： PMC6259796          DOI： 10.1007/s11999.0000000000000265

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  10 in total

1.  Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail?

Authors:  R Wedin; H C F Bauer
Journal:  J Bone Joint Surg Br       Date:  2005-12

2.  What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Authors:  Julie J Willeumier; Mustafa Kaynak; Peer van der Zwaal; Sven A G Meylaerts; Nina M C Mathijssen; Paul C Jutte; Panagiotis Tsagozis; Rikard Wedin; Michiel A J van de Sande; Marta Fiocco; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

3.  When is hemiarthroplasty preferable to intramedullary prophylactic fixation of malignant lesions of the proximal femur?

Authors:  James S Lin; Juan E Santiago-Torres; Joshua S Everhart; Nicole E Zayan; Joel L Mayerson; Thomas J Scharschmidt
Journal:  J Surg Oncol       Date:  2017-08-09       Impact factor: 3.454

4.  Pathological subtrochanteric fractures in 194 patients: a comparison of outcome after surgical treatment of pathological and non-pathological fractures.

Authors:  Rüdiger J Weiss; Wilhelmina Ekström; Bjarne H Hansen; Johnny Keller; Minna Laitinen; Clement Trovik; Olga Zaikova; Rikard Wedin
Journal:  J Surg Oncol       Date:  2012-10-15       Impact factor: 3.454

Review 5.  Outcome after fixation of metastatic proximal femoral fractures: A systematic review of 40 studies.

Authors:  Stein J Janssen; Teun Teunis; Francis J Hornicek; C Niek van Dijk; Jos A M Bramer; Joseph H Schwab
Journal:  J Surg Oncol       Date:  2016-07-03       Impact factor: 3.454

6.  Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.

Authors:  A Lipton; K Fizazi; A T Stopeck; D H Henry; M R Smith; N Shore; M Martin; S Vadhan-Raj; J E Brown; G E Richardson; F Saad; D A Yardley; K Zhou; A Balakumaran; A Braun
Journal:  Eur J Cancer       Date:  2015-12-13       Impact factor: 9.162

7.  Surgical strategy for spinal metastases.

Authors:  K Tomita; N Kawahara; T Kobayashi; A Yoshida; H Murakami; T Akamaru
Journal:  Spine (Phila Pa 1976)       Date:  2001-02-01       Impact factor: 3.468

8.  Scoring system for the preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Y Tokuhashi; H Matsuzaki; S Toriyama; H Kawano; S Ohsaka
Journal:  Spine (Phila Pa 1976)       Date:  1990-11       Impact factor: 3.468

9.  Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients.

Authors:  Laurens Bollen; Yvette M van der Linden; Willem Pondaag; Marta Fiocco; Bas P M Pattynama; Corrie A M Marijnen; Rob G H H Nelissen; Wilco C Peul; P D Sander Dijkstra
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

10.  Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures.

Authors:  H Mirels
Journal:  Clin Orthop Relat Res       Date:  1989-12       Impact factor: 4.176
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.